27
Views
32
CrossRef citations to date
0
Altmetric
Original Article

The Expression and Regulation of Class Ii Antigens in Normal and Inflammatory Bowel Disease Peripheral Blood Monocytes and Intestinal Epithelium

, , , &
Pages 141-149 | Received 18 Sep 1990, Published online: 07 Jul 2009
 

Abstract

Elevated constitutive expression of major histocompatability (MHC) class II antigens occurs in the enterocytes of patients with IBD. It has been suggested that this aberrant expression of class II molecules may play a role in the pathogenesis of IBD. We examined two possible reasons for such a finding. I) Heightened sensitivity of IBD enterocytes to endogenous γ interferon (γIFN) and 2) enhanced endogenous secretion of γ interferon by intestinal cells in close proximity to the enterocytes (lamina propria lymphocytes). Constitutive and γ interferon stimulated HLA-DR and DP density on intestinal epithelial cells (IEC) and peripheral blood monocytes (PBM) from UC patients (IEC n = 13; PBM n = 20), CD patients (IEC n = 14; PBM n = 18) and non-IBD controls (IEC n = 12; PBM n = 20) were measured via flow cytometry (mean channel fluorescence). γIFN production by PHA stimulated and unstimulated lamina propria lymphocyte (LPL) cultures of UC patients (n = 11) CD patients (n = 8) and non-IBD controls (n = 11) was measured using a vesicular stomatitis virus/WISH cell bioassay. We found significantly greater γIFN secretion by IBD-derived PHA stimulated LPL than from non-IBD stimulated controls (CD = 39.4 ± 12.4u; UC 41.5 ± 6.8u; NL = 22.4 ± 8.3u, p < 0.05) while γIFN induced HLA-DR and DP upregulation was no greater in IBD-derived IEC and PBM than in non-IBD controls. We conclude that the elevated constitutive MHC class II expression found in IBD enterocytes is not due to hypersensitivity of these cells to γIFN but is instead due, in part, to greater γIFN secretion by adjacent lamina propria lymphocytes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.